Serkan Yıldırım

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 15, 2026
Treatment Sequencing of CDK4/6 Inhibitors in Bone-Only Hormone Receptor-Positive Metastatic Breast Cancer: Multi-Center Real-World Data Revealing a Numerical Trend Favoring Later-Line Use.

|Dec 24, 2025
Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Büşra Bülbül, Bekir Ucun, Can Cangür

|Jun 16, 2023
Second-Line Chemotherapy in Gastric Cancer: a Retrospective Study.

Serkan Yildirim, Ahmet Özveren

|Jan 05, 2021
Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?

Serkan Yıldırım, A P Erdoğan, M Karateke

Pageof 1

Frequent Collaborators

1 joint publications

Büşra Bülbül

1 joint publications

Bekir Ucun

1 joint publications

Can Cangür

1 joint publications

İrem Turgut Yeğen